Global Extracorporeal CO2 Removal Devices Market Overview

Extracorporeal CO2 Removal Devices Market size is projected to reach USD 79 Million by 2027 from an estimated USD 60.2 Million in 2021, growing at a CAGR of 3.9% globally.

Extracorporeal carbon dioxide removal (ECCO2R) devices are specialist ECMO devices that focus primarily on CO2 removal, lowering PaCO2, and, as a result, decreasing breathing and MV support effort. The lower blood flow across the circuit is a possible benefit of ECCO2R devices. polymethyl pentene (PMP) or siloxane makes up the active membrane. With independent extracorporeal oxygenation, the principle of "apnoeic oxygenation" was born, in which oxygenation by the lungs and dependency on the alveoli is reduced. The circuit chosen determines the basis for optional components such as the pump system in the arrangement. The pump is not required in the construction of arterio-venous ECCO2R circuits, but it is required in the configuration of veno-venous ECCO2R circuits as a low-pressure system. The application of anticoagulants is required to defend thrombus formation within the circuit.

In a protective ventilation environment, the extracorporeal carbon dioxide removal (ECCO(2)R) concept, when utilized as an integrated tool with conventional ventilation, helps to rectify respiratory acidosis caused by tidal volume (Vt) decrease. The extracorporeal membrane oxygenation (ECMO) experience inspired this notion. Extracorporeal support was first introduced by Kolobow and Gattinoni to separate carbon dioxide removal from oxygen uptake. They reasoned that by allowing the lung to 'rest,' oxygenation via mechanical ventilation could be separated from decarboxylation via extracorporeal carbon dioxide removal. A modified ECMO system with veno-venous bypass removes carbon dioxide, while high levels of positive end-expiratory pressure and a respiratory rate of 3-5 breaths/min provide oxygenation. The market is expected to increase significantly over the forecast period, owing to the growing demand for these devices throughout the world. Several technical advancements and tactics have helped to minimize the complexity and size of extracorporeal CO2 removal devices in recent years. Extracorporeal CO2 removal devices have become viable and simple to employ because of several technological advancements. As a result, the market expansion is expected to be aided by technical improvements. In the wake of the Covid-19 crisis, the worldwide market for extracorporeal CO2 removal devices estimated at USD 59.2 million in 2020 is expected to increase to USD 81 million by 2027, with a CAGR of 4.6 % over the forecast period.

Market Dynamics And Key Factors For Extracorporeal CO2 Removal Devices Market

Drivers:

Clinical Benefits Provided by Extracorporeal CO2 Removal Devices

Chronic Obstructive Pulmonary Disease (COPD) is the third biggest cause of mortality globally, according to the World Health Organization (WHO), with 3.23 million fatalities in 2019. More than 80% of these deaths took place in low- and middle-income nations (LMIC). According to the World Health Organization, instances of pulmonary obstructive disease are expected to grow by 2026 as a result of a rise in smoking among the population, which is expected to boost worldwide extracorporeal carbon dioxide removal (ECCO2R) device sales in the following years. Extracorporeal carbon dioxide removal (ECCO2R) is a technique that provides artificial respiratory support by removing CO2 from the bloodstream via an extracorporeal gas exchanger. It is a feature of several extracorporeal life support strategies, including venovenous (VV) and arteriovenous (AV) extracorporeal membrane exchange oxygenation. Low-flow VV devices, which remove CO2 but do not supply oxygen, are emerging as a possible respiratory support method. Although it was originally designed to help patients with ARDS manage their breathing, advances in technology and a better understanding of the technique have allowed it to be used in other clinical syndromes, such as severe asthma or decompensated chronic obstructive pulmonary disease (COPD), as well as a bridge to transplantation. Furthermore, the clinical benefits given by extracorporeal CO2 removal devices are expected to drive revenue growth in the global extracorporeal CO2 removal devices market throughout the forecast period.

Restraints:

The threat of infection, hypoxia, or thrombosis induced by the circuit's limited blood flow might result in serious health problems, posing a long-term barrier to the extracorporeal CO2 removal devices market's growth.

Opportunities:

In the coming years, the development of the newest and most modern treatment devices and equipment for vitalizing blood flow, improving gaseous exchange efficiency inside the body, and providing fast lung support will generate even more profitable growth potential for the extracorporeal CO2 removal devices market.

Market Segmentation

Segmentation Analysis of Extracorporeal CO2 Removal Devices Market:

Based on the product, the extracorporeal CO2 machines segment is expected to dominate the extracorporeal CO2 removal devices market during the forecast period. The features, technology, and gas exchange capabilities of ECCO2R systems differ. They vary from renal dialysis (low blood flow and priming volume) through partial extracorporeal support (ECCO2R) to complete extracorporeal support (ECMO2R) systems capable of removing all CO2 generation and giving flows high enough to boost oxygen delivery and hence offer blood oxygenation. Extracorporeal CO2 removal devices are theoretically easier to use and have less manpower and logistical constraints, which has led to a rise in patient choice. The ability to increase the function of partial extracorporeal CO2 removal has been made possible by technological advancements in ECCO2R and the awareness that ventilation-induced lung damage can occur even when lung-protective ventilation is used. Smaller and more biocompatible ECCO2R devices will be used in the future for patients with moderate-to-severe ARDS, as well as the only supportive modality in patients with hypercapnic respiratory failure. When selecting patients for extracorporeal support, the possible consequences of ECCO2R must be considered.

Based on the access, the venovenous access segment is expected to dominate the extracorporeal CO2 removal devices market during the forecast period. Blood was collected from the central vein through a drainage cannula and pumped across the gas exchange membrane using a roller or centrifugal pump in venovenous access. A new generation of extracorporeal CO2 removal devices has been developed extracorporeal CO2 removal devices in recent years. Effective venovenous extracorporeal CO2 removal devices have been developed and are replacing the arterio-venous approach, which has the advantage of avoiding arterial puncture. The segment's growth is expected to be accelerated as a result of this increase in product utilization.

Based on the application, The Bridge to transplant segment captured the largest revenue extracorporeal CO2 removal devices market share during the forecast period. Patients waiting for lung transplantation that design life-threatening hypercarbia may help from extracorporeal CO2 removal devices by utilizing them as a bridge to transplantation. The growing focus of producers, such as Alung Technologies and Xenios AG, on emerging extracorporeal CO2 removal devices for the bridge to lung transplantation is expected to hasten the extracorporeal CO2 removal devices market growth during the forecast period.

Based on the end-user, the hospital's segment is expected to dominate the market during the forecast period. The segment is supposed to develop increasing hospital admissions, particularly among patients suffering from ARDS as a result of the recent COVID-19 epidemic. In addition, rising incidences of COPD and ARDS are expected to drive up product demand in hospitals.

Regional Analysis of Extracorporeal CO2 Removal Devices Market:

During the projection period, the Asia Pacific region is predicted to have the largest extracorporeal CO2 removal devices market share. The availability of a large patient pool, increased government healthcare expenditure in developing nations such as India and Japan, and expanding awareness of acute respiratory failure are all expected to promote regional market expansion. Market expansion is expected to be aided by government efforts and the high success rate of extracorporeal CO2 removal devices during respiratory procedures.

Over the projection period, the North American region is expected to cover a broad range of extracorporeal CO2 removal devices market growth. Due to the region's large population and low per capita income, there is a great demand for economical treatment choices. As a result, multinational corporations are anticipating regional market growth by investing in developing countries such as China. The North American regional market is expected to develop because of improved healthcare infrastructure and high product usage, particularly during the COVID-19 pandemic in the United States and Canada.

Throughout the forecast period, the Europe area is expected to rise at a spectacular CAGR. The regional extracorporeal CO2 removal devices market is likely to be driven by increased demand for healthcare equipment and the rising prevalence of chronic disorders such as respiratory failure. Favorable reimbursement policies, rising government spending in long-term healthcare, and expanding healthcare research infrastructure are all contributing to the market's growth.

Players Covered in Extracorporeal CO2 Removal Devices Market are:

  • Medtronic
  • Getinge AB
  • Baxter International Inc.
  • Xenios AG
  • Alung Technologies
  • ESTOR SpA
  • Medica SpA
  • Aferectica Srl

COVID-19 Impact on Extracorporeal CO2 Removal Devices Market

The World Health Organization declared COVID-19 an international pandemic on March 11, 2020, and it continues to spread throughout the United States and around the world. As a result of the COVID-19 pandemic, the organizations have experienced delays and disruptions in pre-medical and medical trials, as well as manufacturing, distribution chain, studies, and enhanced operations. COVID-19's global distribution continues to move at a breakneck pace. Given the impact on COVID-19 at the Company, the Company completed and bought an $83,333 mortgage investment under the Paycheck Protection Program in April 2020. COVID-19 has had a global influence on every aspect of the clinical tool industry, including the market for extracorporeal CO2 removal devices since there have been major disruptions to businesses and financial markets all over the world. Medical device businesses first concentrated on the immediate pandemic response: keeping employees safe, ensuring business continuity, and managing massive changes within the healthcare ecosystem. This has also entailed adapting to rapid adjustments within the healthcare setting and changes in patient behavior. Clinicians and businesses are witnessing patient behavior shift in unanticipated ways, forcing service providers to adapt to meet their demands.

It's too early to say whether or whether these changes in behavior are indicative of a longer-term reset of patient expectations and care delivery, but every healthcare practitioner and business leader should keep an eye on this. This should enable a smooth exit from the epidemic as well as a smooth transition to the new normal. While the COVID-19 epidemic is a huge humanitarian disaster, it also gives a chance to improve healthcare services. From the standpoints of both the system and the industry. Taking efforts today to radically reinvent the system, the patient journey, and their interfaces and interactions with healthcare professionals is crucial for forward-thinking firms. The impact of COVID-19 has been declined with the decrease of regular patient visits by enabling only emergency cases. This has elevated the pros and cons of the medical device market, as individuals with cardiovascular diseases and neurological diseases influenced by COVID-19 have severe life-threatening issues that require be screening, diagnosing, and treating, which has increased the need for surgeries. This is expected to propel the growth of the extracorporeal CO2 removal devices market over the forecast period.

Key Industry Developments In Extracorporeal CO2 Removal Devices Market

  • In May 2021, Baxter International Inc. a global leader in acute care has declared the global introduction of PrisMax 2, the latest version of the company's next-generation platform. PrisMax 2 is developed to support the simplified delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while offering hospitals the flexibility to accomplish the unique demands of the intensive care unit (ICU). The PrisMax 2 system features new solutions within the company's TrueVue digital health portfolio, as well as the PrismaLung+ blood-gas exchanger that provides extracorporeal carbon dioxide removal (ECCO2R) therapy to support the management of acute respiratory dysfunction. PrisMax 2 and TrueVue will soon be available to help in more than 20 economies over the United States and Europe. PrismaLung+ is available in select markets in western Europe; it is not currently cleared or approved for application in the United States.
  • In April 2020, ALung Technologies, Inc., the leading supplier of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, declared the latest initiation of commercial development of its next-generation artificial lung, which develop the Company's target on highly efficient gas exchange devices and also broadens its applicable market.

Extracorporeal CO2 Removal Devices Market- In Depth Analysis and Covid-19 Impact
Segmentations by Type
  • Extracorporeal CO2 Machines
  • Disposables
  • Others
by Access
  • Venovenous Access
  • Arteriovenous Access
by Application
  • Chronic Obstructive Pulmonary Disease
  • Bridge to Transplant
  • Others
by End User
  • Clinics
  • Surgical Centers
  • Hospitals
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product
 3.2 By Access
 3.3 By Application
 3.4 By End User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Extracorporeal CO2 Removal Devices Market by Product
 4.1 Extracorporeal CO2 Removal Devices Market Overview Snapshot and Growth Engine
 4.2 Extracorporeal CO2 Removal Devices Market Overview
 4.3 Extracorporeal CO2 Machines
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Extracorporeal CO2 Machines: Grographic Segmentation
 4.4 Disposables
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Disposables: Grographic Segmentation
 4.5 Others
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Others: Grographic Segmentation

Chapter 5: Extracorporeal CO2 Removal Devices Market by Access
 5.1 Extracorporeal CO2 Removal Devices Market Overview Snapshot and Growth Engine
 5.2 Extracorporeal CO2 Removal Devices Market Overview
 5.3 Venovenous Access
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Venovenous Access: Grographic Segmentation
 5.4 Arteriovenous Access
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Arteriovenous Access: Grographic Segmentation

Chapter 6: Extracorporeal CO2 Removal Devices Market by Application
 6.1 Extracorporeal CO2 Removal Devices Market Overview Snapshot and Growth Engine
 6.2 Extracorporeal CO2 Removal Devices Market Overview
 6.3 Chronic Obstructive Pulmonary Disease
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Chronic Obstructive Pulmonary Disease: Grographic Segmentation
 6.4 Bridge to Transplant
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Bridge to Transplant: Grographic Segmentation
 6.5 Others
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Others: Grographic Segmentation

Chapter 7: Extracorporeal CO2 Removal Devices Market by End User
 7.1 Extracorporeal CO2 Removal Devices Market Overview Snapshot and Growth Engine
 7.2 Extracorporeal CO2 Removal Devices Market Overview
 7.3 Clinics
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Clinics: Grographic Segmentation
 7.4 Surgical Centers
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Surgical Centers: Grographic Segmentation
 7.5 Hospitals
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Hospitals: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Extracorporeal CO2 Removal Devices Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Extracorporeal CO2 Removal Devices Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Extracorporeal CO2 Removal Devices Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 MEDTRONIC
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 GETINGE AB
 8.4 BAXTER INTERNATIONAL INC.
 8.5 XENIOS AG
 8.6 ALUNG TECHNOLOGIES
 8.7 ESTOR SPA
 8.8 MEDICA SPA
 8.9 AFERECTICA SRL

Chapter 9: Global Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Product
  9.2.1 Extracorporeal CO2 Machines
  9.2.2 Disposables
  9.2.3 Others
 9.3 Historic and Forecasted Market Size By Access
  9.3.1 Venovenous Access
  9.3.2 Arteriovenous Access
 9.4 Historic and Forecasted Market Size By Application
  9.4.1 Chronic Obstructive Pulmonary Disease
  9.4.2 Bridge to Transplant
  9.4.3 Others
 9.5 Historic and Forecasted Market Size By End User
  9.5.1 Clinics
  9.5.2 Surgical Centers
  9.5.3 Hospitals

Chapter 10: North America Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product
  10.4.1 Extracorporeal CO2 Machines
  10.4.2 Disposables
  10.4.3 Others
 10.5 Historic and Forecasted Market Size By Access
  10.5.1 Venovenous Access
  10.5.2 Arteriovenous Access
 10.6 Historic and Forecasted Market Size By Application
  10.6.1 Chronic Obstructive Pulmonary Disease
  10.6.2 Bridge to Transplant
  10.6.3 Others
 10.7 Historic and Forecasted Market Size By End User
  10.7.1 Clinics
  10.7.2 Surgical Centers
  10.7.3 Hospitals
 10.8 Historic and Forecast Market Size by Country
  10.8.1 U.S.
  10.8.2 Canada
  10.8.3 Mexico

Chapter 11: Europe Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product
  11.4.1 Extracorporeal CO2 Machines
  11.4.2 Disposables
  11.4.3 Others
 11.5 Historic and Forecasted Market Size By Access
  11.5.1 Venovenous Access
  11.5.2 Arteriovenous Access
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Chronic Obstructive Pulmonary Disease
  11.6.2 Bridge to Transplant
  11.6.3 Others
 11.7 Historic and Forecasted Market Size By End User
  11.7.1 Clinics
  11.7.2 Surgical Centers
  11.7.3 Hospitals
 11.8 Historic and Forecast Market Size by Country
  11.8.1 Germany
  11.8.2 U.K.
  11.8.3 France
  11.8.4 Italy
  11.8.5 Russia
  11.8.6 Spain

Chapter 12: Asia-Pacific Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product
  12.4.1 Extracorporeal CO2 Machines
  12.4.2 Disposables
  12.4.3 Others
 12.5 Historic and Forecasted Market Size By Access
  12.5.1 Venovenous Access
  12.5.2 Arteriovenous Access
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Chronic Obstructive Pulmonary Disease
  12.6.2 Bridge to Transplant
  12.6.3 Others
 12.7 Historic and Forecasted Market Size By End User
  12.7.1 Clinics
  12.7.2 Surgical Centers
  12.7.3 Hospitals
 12.8 Historic and Forecast Market Size by Country
  12.8.1 China
  12.8.2 India
  12.8.3 Japan
  12.8.4 Southeast Asia

Chapter 13: South America Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product
  13.4.1 Extracorporeal CO2 Machines
  13.4.2 Disposables
  13.4.3 Others
 13.5 Historic and Forecasted Market Size By Access
  13.5.1 Venovenous Access
  13.5.2 Arteriovenous Access
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Chronic Obstructive Pulmonary Disease
  13.6.2 Bridge to Transplant
  13.6.3 Others
 13.7 Historic and Forecasted Market Size By End User
  13.7.1 Clinics
  13.7.2 Surgical Centers
  13.7.3 Hospitals
 13.8 Historic and Forecast Market Size by Country
  13.8.1 Brazil
  13.8.2 Argentina

Chapter 14: Middle East & Africa Extracorporeal CO2 Removal Devices Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product
  14.4.1 Extracorporeal CO2 Machines
  14.4.2 Disposables
  14.4.3 Others
 14.5 Historic and Forecasted Market Size By Access
  14.5.1 Venovenous Access
  14.5.2 Arteriovenous Access
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Chronic Obstructive Pulmonary Disease
  14.6.2 Bridge to Transplant
  14.6.3 Others
 14.7 Historic and Forecasted Market Size By End User
  14.7.1 Clinics
  14.7.2 Surgical Centers
  14.7.3 Hospitals
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Saudi Arabia
  14.8.2 South Africa

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion
Extracorporeal CO2 Removal Devices Market- In Depth Analysis and Covid-19 Impact
Segmentations by Type
  • Extracorporeal CO2 Machines
  • Disposables
  • Others
by Access
  • Venovenous Access
  • Arteriovenous Access
by Application
  • Chronic Obstructive Pulmonary Disease
  • Bridge to Transplant
  • Others
by End User
  • Clinics
  • Surgical Centers
  • Hospitals
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET COMPETITIVE RIVALRY
TABLE 005. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET THREAT OF NEW ENTRANTS
TABLE 006. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET THREAT OF SUBSTITUTES
TABLE 007. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY PRODUCT
TABLE 008. EXTRACORPOREAL CO2 MACHINES MARKET OVERVIEW (2016-2028)
TABLE 009. DISPOSABLES MARKET OVERVIEW (2016-2028)
TABLE 010. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 011. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY ACCESS
TABLE 012. VENOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
TABLE 013. ARTERIOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
TABLE 014. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY APPLICATION
TABLE 015. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 016. BRIDGE TO TRANSPLANT MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET BY END USER
TABLE 019. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 020. SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
TABLE 021. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 023. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 024. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 025. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 026. N EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 027. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 028. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 029. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 030. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 031. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 032. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 033. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 034. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 035. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 036. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 037. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 041. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY PRODUCT (2016-2028)
TABLE 043. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY ACCESS (2016-2028)
TABLE 044. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY APPLICATION (2016-2028)
TABLE 045. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY END USER (2016-2028)
TABLE 046. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, BY COUNTRY (2016-2028)
TABLE 047. MEDTRONIC: SNAPSHOT
TABLE 048. MEDTRONIC: BUSINESS PERFORMANCE
TABLE 049. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 050. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. GETINGE AB: SNAPSHOT
TABLE 051. GETINGE AB: BUSINESS PERFORMANCE
TABLE 052. GETINGE AB: PRODUCT PORTFOLIO
TABLE 053. GETINGE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. BAXTER INTERNATIONAL INC.: SNAPSHOT
TABLE 054. BAXTER INTERNATIONAL INC.: BUSINESS PERFORMANCE
TABLE 055. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 056. BAXTER INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. XENIOS AG: SNAPSHOT
TABLE 057. XENIOS AG: BUSINESS PERFORMANCE
TABLE 058. XENIOS AG: PRODUCT PORTFOLIO
TABLE 059. XENIOS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. ALUNG TECHNOLOGIES: SNAPSHOT
TABLE 060. ALUNG TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 061. ALUNG TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 062. ALUNG TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. ESTOR SPA: SNAPSHOT
TABLE 063. ESTOR SPA: BUSINESS PERFORMANCE
TABLE 064. ESTOR SPA: PRODUCT PORTFOLIO
TABLE 065. ESTOR SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. MEDICA SPA: SNAPSHOT
TABLE 066. MEDICA SPA: BUSINESS PERFORMANCE
TABLE 067. MEDICA SPA: PRODUCT PORTFOLIO
TABLE 068. MEDICA SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. AFERECTICA SRL: SNAPSHOT
TABLE 069. AFERECTICA SRL: BUSINESS PERFORMANCE
TABLE 070. AFERECTICA SRL: PRODUCT PORTFOLIO
TABLE 071. AFERECTICA SRL: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY PRODUCT
FIGURE 012. EXTRACORPOREAL CO2 MACHINES MARKET OVERVIEW (2016-2028)
FIGURE 013. DISPOSABLES MARKET OVERVIEW (2016-2028)
FIGURE 014. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 015. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY ACCESS
FIGURE 016. VENOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
FIGURE 017. ARTERIOVENOUS ACCESS MARKET OVERVIEW (2016-2028)
FIGURE 018. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY APPLICATION
FIGURE 019. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 020. BRIDGE TO TRANSPLANT MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY END USER
FIGURE 023. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 024. SURGICAL CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 025. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
Please Wait...

Frequently Asked Questions :

What would be forecast period in the market research report?
The forecast period in the market research report is 2022-2028.
Who are the key players in Extracorporeal CO2 Removal Devices market?
The key players mentioned are Medtronic,Getinge AB,Xenios AG,Alung Technologies,ESTOR SpA,Medica SpA,Aferectica Srl.
What are the segments of Extracorporeal CO2 Removal Devices market?
The Extracorporeal CO2 Removal Devices market is segmented into product, access, application, end user and region. By Product, the market is categorized into Extracorporeal Co2 Machines, Disposables, Others). By Access, it is classified into Venovenous Access, Arteriovenous Access. By Application, it is classified into: Chronic Obstructive Pulmonary Disease, Bridge To Transplant, Others. By End User, it is classified into: Clinics, Surgical Centers, Hospitals. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Extracorporeal CO2 Removal Devices market?
Extracorporeal carbon dioxide removal (ECCO2R) devices are specialist ECMO devices that focus primarily on CO2 removal, lowering PaCO2, and, as a result, decreasing breathing and MV support effort. The lower blood flow across the circuit is a possible benefit of ECCO2R devices.
How big is the Extracorporeal CO2 Removal Devices market?
Extracorporeal CO2 Removal Devices Market size is projected to reach USD 79 Million by 2027 from an estimated USD 60.2 Million in 2021, growing at a CAGR of 3.9% globally.